Product Details for: ITVISMA
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intrathecal
4x10^13VG/ML
Single-Dose Vial
351(a)
ITVISMA
Rx
Proper Name
onasemnogene abeparvovec-brve
onasemnogene abeparvovec-brve
BLA Number
125856
125856
Applicant
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc.
Original Approval Date
November 24, 2025
November 24, 2025
Date of First Licensure